Helix works as a population genomics company operating in the healthcare and life sciences sectors. The company provides solutions that enable health systems, public health organizations, and life science companies to integrate genomic data into patient care and public health decision-making. Its primary customers are health systems, public health entities, and life science companies. It was founded in 2015 and is based in San Mateo, California.
Helix's Product Videos
ESPs containing Helix
The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.
The D2C genetic tests market refers to the direct-to-consumer genetic testing category, where individuals can purchase genetic tests without a healthcare provider's involvement. The market promises to provide personalized insights into an individual's genetic makeup, health risks, ancestry, and inherited traits. However, there are concerns about the accuracy and interpretation of results, as well …
Helix's Products & Differentiators
Population Genomics Platform
Driven by the Sequence Once, Query OftenTM model, population genomics with Helix allows health systems to uncover genetic risk more efficiently and utilize genetic insights at the point-of-care. Leading health systems have seen these programs improve care, address health inequities and engage patients & providers, all while reducing costs.
Research containing Helix
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Helix in 6 CB Insights research briefs, most recently on Aug 9, 2023.
Expert Collections containing Helix
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Helix is included in 5 Expert Collections, including Conference Exhibitors.
HLTH is a healthcare event bringing together startups and large companies from pharma, health insurance, business intelligence, and more to discuss the shifting landscape of healthcare
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
60+ underwriting data companies addressing 7 technology priorities, from wearables to genomic screening tools, that life insurance companies face.
Drug Discovery Tech Market Map
This CB Insights Tech Market Map highlights 220 drug discovery companies that are addressing 12 distinct technology priorities that pharmaceutical companies face.
Mental Health Tech
This collection includes companies applying technology to problems of emotional, psychological, and social well-being. Examples include companies working in areas such as substance abuse, eating disorders, stress reduction, depression, PTSD, and anxiety.
Helix has filed 112 patents.
Transcription factors, Genetics, Genomics, Biological databases, Molecular biology
Transcription factors, Genetics, Genomics, Biological databases, Molecular biology
Latest Helix News
Apr 13, 2021
| Ancestry, Color Genomics, Full Genome , Helix OpCo Direct-to-consumer genetic testing is a technique to promote genetic tests to consumers and patients via print media, television, Internet, and the tests are available for sale online or in stores and this marketing is generally done without direct involvement of a health care provider. By SMN Bureau Direct-To-Consumer Genetic Testing Market research report delivers a comprehensive study on production capacity, consumption, import and export for all major regions across the world. Report provides is a professional inclusive study on the current state for the market. Analysis and discussion of important industry like market trends, size, share, growth estimates are mentioned in the report. Request Exclusive Sample PDF of this Report @ https://www.theinsightpartners.com/sample/TIPRE00018484/ Our expert team is consistently working on updated data and information on the key player’s related business processes that value the market. For future strategies and predictions, we provide a special section regarding the COVID-19 situation. MARKET INTRODUCTION Direct-to-consumer genetic testing is a technique to promote genetic tests to consumers and patients via print media, television, Internet, and the tests are available for sale online or in stores and this marketing is generally done without direct involvement of a health care provider. Customers send their DNA (genetic sample) sample directly to the company and the results can be obtained through their website in the form of electronic reports or are sent on home address. This technique is very crucial for people living in urban areas. The DTC testing is mainly of three types, ancestry tests, paternity test and disease risk test. Direct-To-Consumer Genetic Testing Market Competition Landscape and Key Developments: Easy DNA, Ancestry, Color Genomics, Full Genome Corporation, Helix OpCo LLC., Identigene, Karmagenes, FamilytreeDNA, Mapmygenome Pathway Genomes, Genesis Healthcare Direct-To-Consumer Genetic Testing Market Segmental Overview: The report specifically highlights the Direct-To-Consumer Genetic Testing market share, company profiles, regional outlook, product portfolio, a record of the recent developments, strategic analysis, key players in the market, sales, distribution chain, manufacturing, production, new market entrants as well as existing market players, advertising, brand value, popular products, demand and supply, and other important factors related to the market to help the new entrants understand the market scenario better. To comprehend global Direct-To-Consumer Genetic Testing market dynamics in the world mainly, the worldwide market is analyzed across major global regions: North America (United States, Canada and Mexico), Europe (Germany, France, United Kingdom, Russia and Italy), Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia), South America (Brazil, Argentina), Middle East & Africa (Saudi Arabia, UAE, Egypt and South Africa) Our Sample Report Accommodate a Brief Introduction of the research report, TOC, List of Tables and Figures, Competitive Landscape and Geographic Segmentation, Innovation and Future Developments Based on Research Methodology MARKET DYNAMICS The key market drivers for Direct-To-Consumer Genetic Testing Market Includes, rising incidences of genetic disorders across the globe along with rising geriatric population across the globe. Moreover, rising growing demand for service personalization in developed nations and rising public awareness are expected to fuel market growth during forecast period. Whereas, high cost of DTC testing method along with less awareness about DTC testing in developing nations is expected to restrain market growth during forecast period. MARKET SCOPE The "Direct-To-Consumer Genetic Testing Market" is a specialized and in-depth study of the Biotechnology industry with a special focus on the global market trend analysis. The report aims to provide an overview of Direct-To-Consumer Genetic Testing market with detailed market segmentation by type, technology, distribution channel. The Direct-To-Consumer Genetic Testing Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Direct-To-Consumer Genetic Testing Market and offers key trends and opportunities in the market. MARKET SEGMENTATION The Direct-To-Consumer Genetic Testing Market is segmented on the basis of Type, technology and distribution channel. On the basis of type the market is segmented as, carrier testing, predictive testing, nutrigenomic testing and others. On the basis of technology the market is segmented as, targeted analysis, single nucleotide, whole genome sequencing. And on the basis of distribution channel the market is segmented as, over the counter, retail pharmacies, online platforms. Direct-To-Consumer Genetic Testing Market – Key Market Dynamics Direct-To-Consumer Genetic Testing Market – Global Market Analysis Direct-To-Consumer Genetic Testing Market – Revenue and Forecasts to 2027 – Product Type Direct-To-Consumer Genetic Testing Market – Revenue and Forecasts to 2027 – Application Direct-To-Consumer Genetic Testing Market – Revenue and Forecasts to 2027 – Compound Direct-To-Consumer Genetic Testing Market Revenue and Forecasts to 2027 – Geographical Analysis Industry Landscape Appendix
Helix Frequently Asked Questions (FAQ)
When was Helix founded?
Helix was founded in 2015.
Where is Helix's headquarters?
Helix's headquarters is located at 101 S Ellsworth Ave, San Mateo.
What is Helix's latest funding round?
Helix's latest funding round is Grant - II.
How much did Helix raise?
Helix raised a total of $468.9M.
Who are the investors of Helix?
Investors of Helix include The Rockefeller Foundation, Warburg Pincus, Temasek, DFJ Growth Fund, Kleiner Perkins Caufield & Byers and 7 more.
Who are Helix's competitors?
Competitors of Helix include Hurdle, Genomelink, Akkure, Tempus, Veritas Genetics and 7 more.
What products does Helix offer?
Helix's products include Population Genomics Platform and 1 more.
Who are Helix's customers?
Customers of Helix include Renown Health, Mayo Clinic and Medical University of South Carolina.
Compare Helix to Competitors
LetsGetChecked is a virtual care company that operates in the healthcare sector. The company provides telehealth services, pharmacy services, and at-home laboratory tests for a variety of health conditions. These services are primarily aimed at individuals seeking to manage their health from home. It was founded in 2015 and is based in Dublin, Ireland.
Sano is a company that focuses on personalized medicine. The company offers a range of services including recruitment support, protocol development, DNA testing, electronic medical record retrieval, patient engagement, and prescreening and digital consent. Sano primarily works with life science companies and research initiatives. It was founded in 2016 and is based in London, England.
MedySapiens provides genetic analysis test services to global medical institutes by applying biotechnology and artificial intelligence technologies in order to save lives and improve the quality of life for rare disease patients. Its products consist of MedyNA and MedyCVi. The company was founded in 2017 and is based in Seoul, South Korea.
Geneticure tackles the standard of care for chronic and dangerous diseases by providing tools for clinicians to personalize therapy based on the specific patient. It uses pharmacogenomics to develop tests that clinicians use to help patients get better faster, and with less cost. Its post-diagnostic genetic tests ensure each patient receives only the fewest, most effective medications for their unique genetics and save unnecessary medications, visits, and adverse events. The company was founded in 2014 and is based in Rochester, Minnesota.
Eugene is a digital healthcare company that operates in the health technology sector. The company offers at-home genetic tests for reproductive and preventive health, providing insights into preconception, pregnancy, cancer risk, and heart health. These tests are non-invasive, saliva-based, and come with ongoing support from in-house genetic counsellors. It was founded in 2017 and is based in Richmond, Victoria.
Human Longevity is a health intelligence company that operates in the genomics and healthcare sectors. The company offers a precision healthcare program that uses advanced technology to detect and potentially preempt various diseases, including cancer, cardiac, metabolic, and neurodegenerative diseases. The company primarily serves individuals seeking to proactively manage their health and longevity. It was founded in 2013 and is based in San Diego, California.